Login / Signup

Exposure to thioguanine during 117 pregnancies in women with inflammatory bowel disease.

Femke CrouwelMelek SimsekMarjon A de BoerChris J J MulderEmma M van AndelRob H CreemersDirk P van AsseldonkAd A van BodegravenCarmen S HorjusMarijn C VisschedijkAngelique L M WeusthuisMargien L SeinenBindia JharapFiona D M van SchaikIshfaq AhmadPaul J BoekemaGreetje J TackLouktje WormmeesterMaurice W M D LutgensPetra G A van BoeckelLennard P L GilissenMarjon KerkhofMaurice RusselFrank HoentjenMaartje E BartelinkJohan P KuijvenhovenJeroen W J MaljaarsWillemijn A van DopJanneke WondersMichael M P J A van der VoornHans J C BuiterNanne K de Boer
Published in: Journal of Crohn's & colitis (2022)
In this large case series the use of thioguanine during pregnancy is not associated in excess with adverse maternal or neonatal outcomes.
Keyphrases
  • pregnancy outcomes
  • birth weight
  • gestational age
  • preterm birth
  • pregnant women
  • type diabetes
  • emergency department
  • metabolic syndrome
  • physical activity
  • weight gain
  • electronic health record